The enforcement of China’s Antimonopoly Law (AML) remained a priority for the United States throughout 2015, despite the fact that few new cases were launched last year. President Xi Jinping’s September visit to the United States and the November Joint Commission on Commerce and Trade (JCCT) in Guangzhou made progress to improve fair treatment, due process and regulatory transparency in AML cases, and to clarify the relationship between the use of intellectual property (IP) and fair competition.

Preparations for the November 21-23 US-China Joint Commission on Commerce and Trade (JCCT) have kicked into high gear in recent weeks with both an active calendar of working group programs and robust planning for the plenary session in Guangzhou.

US and Chinese negotiators are gearing up for a busy quarter as they head into bilateral and multilateral trade and investment talks. This fall, US negotiators will participate in the US-China Joint Committee on Commerce and Trade (JCCT) negotiations—the primary forum used by both governments to raise industry-specific concerns and discuss cross-cutting issues—as well as prepare for the Asia-Pacific Economic Cooperation (APEC) Economic Leaders’ Meeting.

The United States and China are gearing up for the upcoming Joint Commission on Commerce and Trade (JCCT) meetings in Guangzhou, scheduled for November 22-24.

Suspending problematic policies that restrict US companies’ ability to sell information technology (IT) products in the China market, eliminating proposed regulations that would disadvantage foreign companies operating in certain industries, and enforcing the Antimonopoly Law (AML) fairly against both domestic and foreign companies: these are just some of the US-China Business Council’s (USCBC) new recommendations for the 2015 Joint Commission on Commerce and Trade (JCCT) negotiations.